Home » Topics » BioWorld Science

BioWorld Science
RSS

INS-3001 demonstrates efficacy in rat model of vascular calcifications

Nov. 7, 2018

Discovery of new envelope-based antigen that triggers potent humoral responses against HIV-1

Nov. 7, 2018

Deubiquitinase Usp12 is neuroprotective in Huntington's disease neurons

Nov. 7, 2018

YC-6 exhibits safety and tolerability in first-in-human study

Nov. 7, 2018

GlycoMimetics initiates phase III trial of uproleselan in relapsed/refractory AML

Nov. 7, 2018

Fat and fibroblasts

Nov. 7, 2018

New insights into microexon regulation

Nov. 7, 2018

Silencing SOD1 with miRNA for SOD1-linked ALS

Nov. 7, 2018

Crunching the data on CRP

Nov. 7, 2018

CRISPR bad news, but with a fix

Nov. 7, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...